Where does Omrix Biopharmaceuticals Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Omrix Biopharmaceuticals Ltd. ranks #4,214 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Omrix Biopharmaceuticals Ltd. hold?

Omrix Biopharmaceuticals Ltd. holds 85 US utility patents granted between 2015 and 2025, spanning 26 technology areas.

What is Omrix Biopharmaceuticals Ltd.'s Innovation Score?

Omrix Biopharmaceuticals Ltd. has an Innovation Score of 45.1 out of 100 (top 24% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Omrix Biopharmaceuticals Ltd.'s patent grant rate increasing or decreasing?

Omrix Biopharmaceuticals Ltd.'s recent grant velocity is -5% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Omrix Biopharmaceuticals Ltd.'s patents?

Omrix Biopharmaceuticals Ltd.'s patents average 10.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Omrix Biopharmaceuticals Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Omrix Biopharmaceuticals Ltd.

Q: What technology areas does Omrix Biopharmaceuticals Ltd. focus on?

Omrix Biopharmaceuticals Ltd.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 47 patents. Grants appear in 26 CPC subclasses total.

USPTO PatentsView assignee record - 85 granted patents across 26 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Omrix ranks #4,214 of 49,997 tracked US assignees by granted-patent volume, with 85 patents across 26 technology areas.

#4,214
of 49,997 US assignees by volume: Top 24%
by Innovation Score (45.1/100): 10.1
avg claims per patent: -5%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4214 · Foreign Corporation #4,214 · 85 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 85 grants
TOP-DECILE #4,214/49,997
PHOTO-FINISH Nobel Biocare Services
CPC-FOCUS A61K · 26 areas
INNOV-PAR 45.1/100
CLAIMS-PAR 10.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT -5% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nobel Biocare Services AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Academisch Ziekenhui… · near

45
Bracco Imaging S P A · near

45
La-Z-Boy Incorporated · near

45
Omrix Biopharmaceuti… · this assignee

45
Withings · near

45
3D Lighting… · lowest

7

What this shows Omrix's Innovation Score is 45.1/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Omrix's grants concentrate

Omrix Biopharmaceuticals Ltd. is a focused PatentsView assignee: 26 CPC subclasses with 55.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2018 (15 grants) versus a trough of 5 in 2017. By volume, Omrix sits between NV Bekaert SA and Rotation Medical, Inc..

Omrix's three-year grant acceleration

From 2019–2021 to 2022–2024, Omrix Biopharmaceuticals Ltd. moved from 25 to 21 grants (0.84x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Bekaert

85
Nobel Biocare Ser…

85
O&M Halyard

85
Océ Holding B V

85
Otto Bock Healthc…

85
Pindrop Security

85
Polygroup Macau (…

85
Rotation Medical

85
Omrix Biopharmace… ◀

85

What this shows Omrix holds 85 patents at rank #4,214, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Omrix

By rank, the assignees closest to #4,214 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Omrix's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Omrix, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Bracco Imaging S.P.A. 45 Academisch Ziekenhuis Leiden (H.O.D.N. LUMC) GMBH 45 La-Z-Boy Incorporated 45 Withings 45

Similar claim depth

Nearest assignees by average claims per patent (10.1 here).

Nerviano Medical Sciences S.R.L. 10.1 avg Fujitsu TEN Limited 10.1 avg Niagara Bottling, LLC 10.1 avg Zhen Ding Technology Co., Ltd. 10.1 avg

Omrix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Omrix Biopharmaceuticals Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	8	9.4%
2016	8	9.4%
2017	5	5.9%
2018	15	17.6%
2019	6	7.1%
2020	7	8.2%
2021	12	14.1%
2022	5	5.9%
2023	6	7.1%
2024	10	11.8%
2025partial year	3	3.5%

Which technologies does Omrix Biopharmaceuticals Ltd. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 47

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 44

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 37

C12Y - Enzymes 28

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 18

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 17

C07K - Peptides 17

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 15

A61B - DIAGNOSIS; SURGERY; Identification 14

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 11

Y02A - Technologies FOR Adaptation TO Climate Change 3

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 3

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 3

B01D - Separation 3

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 2

Top 15 of 26 technology areas

Where it ranks

Overall rank by patents

#4,214

of 49,997 tracked assignees

Innovation Score

45.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Omrix Biopharmaceuticals Ltd.'s patent record in context - here's where to go next.

Omrix Biopharmaceuticals Ltd.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 55.3% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #4,214 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Omrix Biopharmaceuticals Ltd. against NV Bekaert SA, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.